Ads
related to: fda, pharmaceuticals
Search results
FDA Considers a Big Change to Decaf Coffee
newser· 22 hours agoThe request: Groups including the Environmental Defense Fund petitioned the FDA to ban the carcinogen, which is used "in many different industries...
FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD
Zacks via Yahoo Finance· 3 days agoPer the FDA, the data submitted by Sanofi (SNY)/Regeneron (REGN) for Dupixent in COPD indication...
FDA considers weekly insulin for diabetics - ABC Columbia
ABC Columbia· 6 days agoA U.S. Food and Drug Administration Advisory Committee is considering the benefits of a weekly...
FDA prioritizes review of Jazz Pharmaceuticals' new cancer therapy By Investing.com
Investing.com· 5 days agoJazz Pharmaceuticals (NASDAQ:JAZZ) announced that the U.S. Food and Drug Administration (FDA) has...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 9 hours agoTelix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has completed the submission of a Biologics...Application (BLA) to the United States ( ...
FDA approves Teva Pharmaceuticals’ AUSTEDO XR for TD and HD chorea
Pharmaceutical Technology via Yahoo Finance· 4 days agoIn April 2024, Teva Pharmaceuticals and Alvotech announced FDA approval for Selarsdi...
Pentagon's 'barbaric' drug testing on beagles raises hackles of pet-loving politicians
Fox News· 59 minutes agoPet lovers in Congress are outraged over a new discovery that the Pentagon is reportedly funding...
FDA Extends Review Deadline For Regeneron/Sanofi's Dupixent For 'Smoker's Lungs' Disease
Benzinga via Yahoo Finance· 3 days agoOn Friday, the FDA extended the target action date of priority review of supplemental application...
FDA approves higher dose of Catalyst's LEMS drug By Investing.com
Investing.com· 4 days agoCatalyst Pharmaceuticals, Inc. (NASDAQ: CPRX), a commercial-stage biopharmaceutical company,...
FDA sets review date for Iterum's urinary infection drug By Investing.com
Investing.com· 3 days agoIterum Therapeutics plc (NASDAQ:ITRM), a clinical-stage pharmaceutical company, announced today that...